Biotech · Private company
Entero Therapeutics
Track this companyFree. Adds Entero Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials70 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- adrulipasePhase 2 · Exocrine Pancreatic InsufficiencyClinicalTrials.gov · fetched Nov 12, 2026
- LatiglutenasePhase 2 · Celiac DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- MS1819Phase 2 · Exocrine Pancreatic Insufficiency (EPI)ClinicalTrials.gov · fetched Nov 12, 2026
- NiclosamidePhase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- Porcine PERTPhase 2 · Exocrine Pancreatic Insufficiency (EPI)ClinicalTrials.gov · fetched Nov 12, 2026
- SimvastatinPhase 1 · Celiac DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic FibrosisPHASE2 · COMPLETED · started Feb 1, 2023ClinicalTrials.gov NCT05719311 · fetched Nov 12, 2026
- Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal InfectionPHASE2 · TERMINATED · started Apr 30, 2021ClinicalTrials.gov NCT04858425 · fetched Nov 12, 2026
- Study of Latiglutenase in T1D/CD PatientsPHASE2 · TERMINATED · started Apr 6, 2021ClinicalTrials.gov NCT04839575 · fetched Nov 12, 2026
- OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic FibrosisPHASE2 · COMPLETED · started Jul 20, 2020ClinicalTrials.gov NCT04375878 · fetched Nov 12, 2026
- Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD PatientsPHASE2 · TERMINATED · started Nov 1, 2019ClinicalTrials.gov NCT04243551 · fetched Nov 12, 2026
- OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic FibrosisPHASE2 · COMPLETED · started Jan 10, 2019ClinicalTrials.gov NCT03746483 · fetched Nov 12, 2026
- Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]EARLY_PHASE1 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT03011931 · fetched Nov 12, 2026